株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

バイオセンサーの世界市場予測 2022年:ポイントオブケア (POC)・在宅診断・研究ラボ・バイオディフェンス・環境モニタリング・飲食品産業

Biosensors Market by Application (POC, Home Diagnostics, Research Labs, Biodefense, Environmental Monitoring, Food & Beverages Industry), Technology, Product (Wearable and Non-Wearable), and Geography - Global Forecast to 2022

発行 MarketsandMarkets 商品コード 324151
出版日 ページ情報 英文 184 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.24円で換算しております。
Back to Top
バイオセンサーの世界市場予測 2022年:ポイントオブケア (POC)・在宅診断・研究ラボ・バイオディフェンス・環境モニタリング・飲食品産業 Biosensors Market by Application (POC, Home Diagnostics, Research Labs, Biodefense, Environmental Monitoring, Food & Beverages Industry), Technology, Product (Wearable and Non-Wearable), and Geography - Global Forecast to 2022
出版日: 2017年04月17日 ページ情報: 英文 184 Pages
概要

世界のバイオセンサー市場規模は、2017年から2022年にかけて8.84%のCAGR (年間複合成長率) で推移し、2016年の159億6,000万米ドルから、2022年までに270億6,000万米ドルに達すると予測されています。

当レポートでは、世界のバイオセンサー市場について調査分析し、製品、技術、用途、および地域別の市場分析と予測を提供するほか、競合状況および主要企業のプロファイルをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • バイオセンサー市場における魅力的な成長機会
  • バイオセンサー市場:用途別
  • バイオセンサー市場:技術・地域別
  • バイオセンサー市場:製品別
  • バイオセンサー市場:国別

第5章 市場概要

  • イントロダクション
  • 市場ダイナミクス
    • 促進因子
    • 抑制因子
    • 機会
    • 課題

第6章 産業動向

  • イントロダクション
  • バリューチェーン分析
  • 産業動向
  • ポーターのファイブフォース分析
  • 新興動向

第7章 市場:技術別

  • イントロダクション
  • 電気化学バイオセンサー
    • 電流測定バイオセンサー
    • 電位差バイオセンサー
    • 電気伝導測定バイオセンサー
  • 光バイオセンサー
    • 表面プラズモン共鳴 (SPR) バイオセンサー
    • 熱量測定バイオセンサー
    • 蛍光バイオセンサー
  • 圧電バイオセンサー
    • アコースティックバイオセンサー
    • マイクロカンチレバーバイオセンサー
  • 熱バイオセンサー
  • ナノメカニカルバイオセンサー
  • その他

第8章 バイオセンサー市場分析:製品別

  • イントロダクション
  • ウェアラブルバイオセンサー
    • リストウェア
    • アイウェア
    • フットウェア
    • ネックウェア
    • ボディウエア
    • その他
  • 非ウェアラブルバイオセンサー

第9章 バイオセンサー市場:用途別

  • イントロダクション
  • ポイントオブケア (POC)
    • POC用途向けバイオセンサー市場:地域別
    • グルコースモニタリング
    • 心臓マーカー
    • 感染症
    • 凝固モニタリング
    • 妊娠 & 受胎検査
    • 血液ガス & 電解質
    • 腫瘍または癌マーカー
    • 尿検査
    • コレステロール検査
    • その他
  • 在宅診断
  • 研究ラボ
    • 創薬
  • バイオディフェンス
    • 犯罪捜査
  • 環境モニタリング
    • 廃水処理
  • 飲食品産業

第10章 バイオセンサー市場分析:地域別

  • イントロダクション
  • 北米
  • 欧州
  • APAC (アジア太平洋地域)
  • その他の地域 (ROW)

第11章 競合情勢

  • 概要
  • 主要企業
  • DIVEチャート分析
  • 競合ベンチマーキング

第12章 企業プロファイル

  • イントロダクション
  • ABBOTT POINT OF CARE, INC.
  • F. HOFFMAN-LA ROCHE LTD.
  • MEDTRONIC INC.
  • UNIVERSAL BIOSENSORS, INC.
  • SIEMENS AG
  • LIFESCAN, INC.
  • LIFESENSORS, INC.
  • NOVA BIOMEDICAL
  • ACON LABORATORIES, INC.
  • PHARMACO-KINESIS CORPORATION
  • BAYER HEALTHCARE AG
  • BIO-RAD LABORATORIES, INC.
  • BIACORE
  • BIOSENSORS INTERNATIONAL PTE. LTD.
  • ERCON, INC.
  • DUPONT
  • SYSMEX CORPORATION

第13章 付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: SE 3097

"Increasing requirement for glucose monitoring for diabetic individuals worldwide is fueling the growth of the biosensors market"

The biosensors market is expected to grow at a CAGR of 8.84% between 2017 and 2022 to reach USD 27.06 billion by 2022 from USD 15.96 billion in 2016. Glucose monitoring devices are gaining traction due to increasing incidences and prevalence of lifestyle diseases, such as diabetes, that require regular monitoring. Moreover, the proven efficacy of such testing kits has resulted in their growing adoption by doctors. According to International Diabetes Federation, the number of people suffering from diabetes is expected to grow from 415 million in 2015 to almost 642 million by 2040 worldwide.

"Increasing demand for point-of-care applications is driving the growth of the biosensors market."

The increasing demand for biosensors is attributed to the availability of point-of-care testing methods. As most POC tests are in the vicinity of patient care sites, the requirement for complex infrastructure and training is low. The growth in the POC market is attributed to the advancements in biosensors technology and increasing demand for quick test results. Also, growing prevalence of infectious and lifestyle diseases, such as cardiac complications and diabetes, is increasing the demand for POC diagnostics. Awareness among people for easy and convenient ways to get faster test results is also contributing to the growing demand. Also, physicians prefer POC for quick decision-making to prescribe disease-specific drugs. On the contrary, doctors previously had to wait before starting with symptomatic treatment, as test procedures used to take a considerably longer amount of time to yield results.

"North America is the major market for biosensors."

North America is likely to hold the largest share of the overall biosensors market in 2017. POC diagnostics is the fastest-growing applications for biosensors in North America. The main reason behind the growth of the POC segment is the increase in addressable patient population base. According to the American Medical Association and American Medical Group Association, more than 50% Americans were living with one or more chronic disease(s) till 2012. The number of Americans suffering from chronic diseases was around 125 billion in 2000, which is expected to reach around 157 billion by 2022. The baby boomer population is witnessing a growth in incidences of chronic and infectious diseases, According to the US Census Bureau, the number of individuals over the age of 65 was 39.6 billion in 2009, which is expected to increase to 72.1 billion by 2030.

The biosensors market APAC is expected grow at a high rate between 2017 and 2022. The other major factors contributing to the growth of the biosensors market in APAC include the development of healthcare systems and increasing number of lifestyle diseases in the region. APAC is the amalgamation of some of the leading markets such as China, Japan, and India. The growth of the biosensors market in APAC for POC applications can be attributed to the huge population base, increasing investments in the healthcare sector, growing focus of key industry players on technological advancements, and significant R&D pertaining to biosensors. In September 2017, PatientSafe Solutions (US) garnered strategic investments of around USD 27 billion from EDBI. This fund was used to augment the expansion of PatientSafe's PatientTouch System, a POC mobile solution, in APAC.

In the process of determining and verifying the market size for several segments and subsegments gathered through secondary research, extensive primary interviews have been conducted with key officials in the biosensors industry. The break-up of the primary participants has been shown below.

  • By Company Type: Tier 1 = 35 %, Tier 2 = 45%, and Tier 3 = 20%
  • By Designation: C-Level Executives = 35%, Directors = 25%, and Others = 40%
  • By Region: North America = 45%, Europe = 20%, APAC = 30%, and RoW = 5%

The report also profiles the key players in the biosensors market and analyzes their market ranking. The prominent players profiled in this report are Abbott Point of Care Inc. (US), Medtronic, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), Siemens AG (Germany), LifeScan, Inc. (US), LifeSensors Inc. (US), Nova Biomedical Corp. (US), Acon Laboratories Inc. (US), Universal Biosensors (Australia), Pharmaco-Kinesis Corporation (PKC) (US), Bayer Healthcare AG (Germany), Biacore (UK), Bio-Rad Laboratories Inc. (US), Biosensors International Ltd.(Singapore), Ercon, Inc. (US), DuPont (US), and Sysmex Corporation (Japan).

Research Coverage:

This research report categorizes the biosensors market on the basis of application, technology, product, and geography. The report also provides the Porter's five forces analysis, along with a description of each of its forces and their respective impact on the biosensors market; description of major drivers, restraints, challenges, and opportunities pertaining to the market; value chain analysis; and market ranking analysis.

Reasons to Buy the Report:

The report will help leaders/new entrants in this market in the following ways:

  • 1. This report segments the biosensors market comprehensively and provides the closest market size estimation for all subsegments across different regions.
  • 2. The report will help stakeholders understand the pulse of the market and provide them with the information on key drivers, restraints, challenges, and opportunities for the biosensors market.
  • 3. This report will help stakeholders understand their competitors better and gain more insights to improve their position in the business. The competitive landscape section describes competitor ecosystem and various strategies implemented by the companies such as new product developments, partnerships, and mergers and acquisitions.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. STUDY SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THIS STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. List of major secondary sources
      • 2.1.1.2. Key data from secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Primary interviews with experts
      • 2.1.2.2. Breakdown of primaries
      • 2.1.2.3. Key data from primary sources
      • 2.1.2.4. Key industry insights
  • 2.2. MARKET SIZE ESTIMATION
    • 2.2.1. BOTTOM-UP APPROACH
    • 2.2.2. TOP-DOWN APPROACH
      • 2.2.2.1. Estimating value and volume from secondary treasures
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. ASSUMPTIONS

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. ATTRACTIVE GROWTH OPPORTUNITIES IN THE BIOSENSORS MARKET
  • 4.2. BIOSENSORS MARKET, BY APPLICATION
  • 4.3. BIOSENSORS MARKET, BY TECHNOLOGY AND REGION
  • 4.4. BIOSENSORS MARKET, BY PRODUCT
  • 4.5. BIOSENSORS MARKET, BY COUNTRY

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Emergence of nanotechnology-based biosensors
      • 5.2.1.1. Significant technological advancements in the past few years
      • 5.2.1.2. Increasing use of biosensors to monitor glucose levels in individuals with diabetes
      • 5.2.1.3. Increased demand for home-based POC devices
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Slow rate of commercialization
      • 5.2.2.2. High costs involved in research and development
      • 5.2.2.3. Reluctance toward the adoption of new treatment practices
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Emerging market in developing countries
      • 5.2.3.2. High-growth opportunities in environmental monitoring, biodefense, and the food industry
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Government regulations - long certification and approval cycles
      • 5.2.4.2. Pricing pressure in the POC market

6. INDUSTRY TRENDS

  • 6.1. INTRODUCTION
  • 6.2. VALUE CHAIN ANALYSIS
  • 6.3. INDUSTRY TRENDS
  • 6.4. PORTER'S FIVE FORCES ANALYSIS
    • 6.4.1. THREAT OF NEW ENTRANTS
    • 6.4.2. THREATS OF SUBSTITUTES
    • 6.4.3. BARGAINING POWER OF SUPPLIERS
    • 6.4.4. BARGAINING POWER OF BUYERS
    • 6.4.5. INTENSITY OF COMPETITIVE RIVALRY
  • 6.5. STARTUP SCENARIO
    • 6.5.1. START-UP COMPANIES

7. MARKET, BY TECHNOLOGY

  • 7.1. INTRODUCTION
  • 7.2. ELECTROCHEMICAL BIOSENSORS
    • 7.2.1. AMPEROMETRIC SENSORS
      • 7.2.1.1. Blood glucose sensors
    • 7.2.2. POTENTIOMETRIC SENSORS
      • 7.2.2.1. Immunosensors
    • 7.2.3. CONDUCTOMETRIC SENSORS
  • 7.3. OPTICAL BIOSENSORS
    • 7.3.1. SURFACE PLASMON RESONANCE (SPR)
    • 7.3.2. CALORIMETRIC BIOSENSORS
    • 7.3.3. FLUORESCENCE BIOSENSORS
  • 7.4. PIEZOELECTRIC BIOSENSORS
    • 7.4.1. ACOUSTIC BIOSENSORS
    • 7.4.2. MICROCANTILEVER BIOSENSORS
  • 7.5. THERMAL BIOSENSORS
  • 7.6. NANOMECHANICAL BIOSENSORS
  • 7.7. OTHERS

8. BIOSENSORS MARKET, BY PRODUCT

  • 8.1. INTRODUCTION
  • 8.2. WEARABLE BIOSENSORS
    • 8.2.1. WRISTWEAR
    • 8.2.2. EYEWEAR
    • 8.2.3. FOOTWEAR
    • 8.2.4. NECKWEAR
    • 8.2.5. BODYWEAR
    • 8.2.6. OTHERS
  • 8.3. NON-WEARABLE BIOSENSORS

9. BIOSENSORS MARKET, BY APPLICATION

  • 9.1. INTRODUCTION
  • 9.2. POINT OF CARE (POC)
    • 9.2.1. BIOSENSORS MARKET FOR POC APPLICATIONS, BY GEOGRAPHY
    • 9.2.2. GLUCOSE MONITORING
    • 9.2.3. CARDIAC MARKERS
    • 9.2.4. INFECTIOUS DISEASES
    • 9.2.5. COAGULATION MONITORING
    • 9.2.6. PREGNANCY & FERTILITY TESTING
    • 9.2.7. BLOOD GAS & ELECTROLYTES
    • 9.2.8. TUMOR OR CANCER MARKERS
    • 9.2.9. URINALYSIS TESTING
    • 9.2.10. CHOLESTEROL TESTS
    • 9.2.11. OTHERS
  • 9.3. HOME DIAGNOSTICS
  • 9.4. RESEARCH LABS
    • 9.4.1. DRUG DEVELOPMENT
  • 9.5. BIODEFENCE
    • 9.5.1. CRIME DETECTION
  • 9.6. ENVIRONMENTAL MONITORING
    • 9.6.1. WASTEWATER TREATMENT
  • 9.7. FOOD & BEVERAGES INDUSTRY

10. BIOSENSORS MARKET, BY GEOGRAPHY

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
  • 10.3. EUROPE
  • 10.4. ASIA PACIFIC (APAC)
  • 10.5. REST OF THE WORLD (ROW)

11. COMPETITIVE LANDSCAPE

  • 11.1. OVERVIEW
  • 11.2. KEY PLAYERS IN BIOSENSORS MARKET
  • 11.3. DIVE CHART ANALYSIS
    • 11.3.1. VANGUARDS
    • 11.3.2. DYNAMIC
    • 11.3.3. INNOVATOR
    • 11.3.4. EMERGING
  • 11.4. COMPETITIVE BENCHMARKING
    • 11.4.1. PRODUCT OFFERINGS
    • 11.4.2. BUSINESS STRATEGY

Top 25 companies analyzed for this study are - F. Hoffman-La Roche Ltd. (Switzerland), Abbott Point of Care Inc. (US), Medtronic, Inc. (US), LifeScan Inc. (US), Universal Biosensors Inc. (Australia), DuPont (US), Sysmex Corporation (Japan), Bio-Rad laboratories Inc. (US), Pharmaco-Kinesis Corporation (PKC) (US), Nova Biomedical Corp. (US), ACON Laboratories, Inc. (US), LifeSensors Inc. (US), Biacore (Sweden), Biosensors International Pte. Ltd. (US), Innovative Biosensors, Inc. (US), Xsensio (Switzerland), Theron, Inc. (US), Cranfield Biotechnology Centre (UK), Ercon, Inc. (US), Bio-Rad Laboratories Inc. (US), Draeger Safety (US), Molecular Devices Corp. (US), M-Biotech, NeuroSky, Inc. (US), and QTL Biosystems, LLC (US)

  • 11.5. COMPETITIVE SITUATIONS AND TRENDS
    • 11.5.1. NEW PRODUCT LAUNCHES AND DEVELOPMENTS
    • 11.5.2. PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS
    • 11.5.3. MERGERS AND ACQUISITIONS
    • 11.5.4. EXPANSIONS

12. COMPANY PROFILES (Business Overview, Products offered & Services strategies, Key Insights, Recent Developments, MnM View)*

  • 12.1. INTRODUCTION
  • 12.2. ABBOTT POINT OF CARE, INC.
  • 12.3. F. HOFFMAN-LA ROCHE LTD.
  • 12.4. MEDTRONIC INC.
  • 12.5. UNIVERSAL BIOSENSORS, INC.
  • 12.6. SIEMENS AG
  • 12.7. LIFESCAN, INC.
  • 12.8. LIFESENSORS, INC.
  • 12.9. NOVA BIOMEDICAL
  • 12.10. ACON LABORATORIES, INC.
  • 12.11. PHARMACO-KINESIS CORPORATION
  • 12.12. BAYER HEALTHCARE AG
  • 12.13. BIO-RAD LABORATORIES, INC.
  • 12.14. BIACORE
  • 12.15. BIOSENSORS INTERNATIONAL PTE. LTD.
  • 12.16. ERCON, INC.
  • 12.17. DUPONT
  • 12.18. SYSMEX CORPORATION
  • 12.19. KEY INNOVATORS
    • 12.19.1. NEUROSKY, INC.
    • 12.19.2. GRAPHENE FRONTIERS
    • 12.19.3. HMICRO INC.

*Details on Business Overview, Products offered & Services strategies, Key Insights, Recent Developments, MnM View might not be captured in case of unlisted companies.

13. APPENDIX

  • 13.1. INSIGHTS OF INDUSTRY EXPERTS
  • 13.2. DISCUSSION GUIDE
  • 13.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 13.5. AVAILABLE CUSTOMIZATIONS
  • 13.6. RELATED REPORTS
  • 13.7. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: BIOSENSORS MARKET, BY TECHNOLOGY, 2015-2022 (USD BILLION)
  • TABLE 2: DIFFERENCES BETWEEN VARIOUS ELECTROCHEMICAL BIOSENSORS
  • TABLE 3: GLUCOSE SENSORS AND DEVICES APPROVED BY FOOD AND DRUG ADMINISTRATION (FDA)
  • TABLE 4: MARKET FOR ELECTROCHEMICAL BIOSENSORS, BY TECHNOLOGY, 2015-2022 (USD BILLION)
  • TABLE 5: MARKET FOR OPTICAL BIOSENSORS, BY TECHNOLOGY, 2015-2022 (USD BILLION)
  • TABLE 6: BIOSENSORS MARKET, BY PRODUCT, 2015-2022 (USD BILLION)
  • TABLE 7: MARKET FOR WEARABLE BIOSENSORS, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 8: MARKET FOR WRISTWEAR BIOSENSORS, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 9: MARKET FOR EYEWEAR HEADWEAR BIOSENSORS, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 10: MARKET FOR FOOTWEAR BIOSENSORS, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 11: MARKET FOR NECKWEAR BIOSENSORS, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 12: MARKET FOR BODYWEAR BIOSENSORS, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 13: MARKET FOR OTHER WEARABLE BIOSENSORS, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 14: MARKET FOR NON-WEARABLE BIOSENSORS, BY APPLICATION, 2015-2022 (USD BILLION)
  • TABLE 15: BIOSENSORS MARKET, BY APPLICATION, 2015-2022 (USD BILLION)
  • TABLE 16: BIOSENSORS MARKET FOR POC APPLICATIONS, BY TYPE, 2015-2022 (USD BILLION)
  • TABLE 17: BIOSENSORS MARKET FOR POC APPLICATIONS, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 18: BIOSENSORS MARKET FOR POC APPLICATIONS IN NORTH AMERICA, BY COUNTRY, 2015-2022 (USD BILLION)
  • TABLE 19: BIOSENSORS MARKET FOR POC APPLICATIONS IN EUROPE, BY COUNTRY/REGION, 2015-2022 (USD BILLION)
  • TABLE 20: BIOSENSORS MARKET FOR POC APPLICATIONS IN APAC, BY COUNTRY/REGION, 2015-2022 (USD BILLION)
  • TABLE 21: BIOSENSORS MARKET FOR POC APPLICATIONS, BY PRODUCT, 2015-2022 (USD BILLION)
  • TABLE 22: MARKET FOR WEARABLE BIOSENSORS FOR POC APPLICATIONS, BY TYPE, 2015-2022 (USD BILLION)
  • TABLE 23: BIOSENSORS MARKET FOR GLUCOSE MONITORING, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 24: BIOSENSORS MARKET FOR CARDIAC MARKERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 25: BIOSENSORS MARKET FOR INFECTIOUS DISEASES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 26: BIOSENSORS MARKET FOR COAGULATION MONITORING, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 27: BIOSENSORS MARKET FOR PREGNANCY & FERTILITY TESTING, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 28: BIOSENSORS MARKET FOR BLOOD GAS & ELECTROLYTES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 29: BIOSENSORS MARKET FOR TUMOR OR CANCER MARKERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 30: BIOSENSORS MARKET FOR URINALYSIS TESTING, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 31: BIOSENSORS MARKET FOR CHOLESTEROL TESTS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 32: BIOSENSORS MARKET FOR OTHER POC APPLICATIONS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 33: BIOSENSORS MARKET FOR HOME DIAGNOSTICS APPLICATIONS, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 34: BIOSENSORS MARKET FOR HOME DIAGNOSTICS APPLICATIONS IN NORTH AMERICA, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 35: BIOSENSORS MARKET FOR HOME DIAGNOSTICS APPLICATIONS IN EUROPE, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 36: BIOSENSORS MARKET FOR HOME DIAGNOSTICS APPLICATIONS IN APAC, BY COUNTRY/REGION, 2015-2022 (USD BILLION)
  • TABLE 37: BIOSENSORS MARKET FOR HOME DIAGNOSTICS APPLICATIONS, BY PRODUCT, 2015-2022 (USD BILLION)
  • TABLE 38: MARKET FOR WEARABLE BIOSENSORS FOR HOME DIAGNOSTICS APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 39: BIOSENSORS MARKET FOR RESEARCH LAB APPLICATIONS, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 40: BIOSENSORS MARKET FOR RESEARCH LAB APPLICATIONS IN NORTH AMERICA, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 41: BIOSENSORS MARKET FOR RESEARCH LAB APPLICATIONS IN EUROPE, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 42: BIOSENSORS MARKET FOR RESEARCH LAB APPLICATIONS IN APAC, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 43: BIOSENSORS MARKET FOR RESEARCH LAB APPLICATIONS, BY PRODUCT, 2015-2022 (USD BILLION)
  • TABLE 44: MARKET FOR WEARABLE BIOSENSORS FOR RESEARCH LAB APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 45: BIOSENSORS MARKET FOR BIODEFENSE APPLICATIONS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 46: BIOSENSORS MARKET FOR BIODEFENSE APPLICATIONS IN NORTH AMERICA, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 47: BIOSENSORS MARKET FOR BIODEFENSE APPLICATIONS IN EUROPE, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 48: BIOSENSORS MARKET FOR BIODEFENSE APPLICATIONS IN APAC, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 49: BIOSENSORS MARKET FOR BIODEFENSE APPLICATIONS, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 50: MARKET FOR WEARABLE BIOSENSORS FOR BIODEFENSE APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 51: BIOSENSORS MARKET FOR ENVIRONMENTAL MONITORING APPLICATIONS, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 52: BIOSENSORS MARKET FOR ENVIRONMENTAL MONITORING APPLICATIONS IN NORTH AMERICA, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 53: BIOSENSORS MARKET FOR ENVIRONMENTAL MONITORING APPLICATIONS IN EUROPE, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 54: BIOSENSORS MARKET FOR ENVIRONMENTAL MONITORING APPLICATIONS IN APAC, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 55: BIOSENSORS MARKET FOR ENVIRONMENTAL MONITORING APPLICATIONS, BY PRODUCT, 2015-2022 (USD BILLION)
  • TABLE 56: MARKET FOR WEARABLE BIOSENSORS FOR ENVIRONMENTAL MONITORING APPLICATIONS, BY TYPE, 2015-2022 (USD BILLION)
  • TABLE 57: ENZYME BIOSENSOR FOR DETECTING FOOD COMPONENTS
  • TABLE 58: BIOSENSORS MARKET FOR FOOD & BEVERAGES INDUSTRY, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 59: BIOSENSORS MARKET FOR THE FOOD & BEVERAGES INDUSTRY IN NORTH AMERICA, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 60: BIOSENSORS MARKET FOR THE FOOD & BEVERAGES INDUSTRY IN EUROPE, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 61: BIOSENSORS MARKET FOR THE FOOD & BEVERAGES INDUSTRY IN APAC, BY COUNTRY/REGION, 2015-2022 (USD BILLION)
  • TABLE 62: BIOSENSORS MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 63: BIOSENSORS MARKET IN NORTH AMERICA, BY COUNTRY, 2015-2022 (USD BILLION)
  • TABLE 64: BIOSENSORS MARKET IN NORTH AMERICA, BY APPLICATION, 2015-2022 (USD BILLION)
  • TABLE 65: BIOSENSORS MARKET IN EUROPE, BY COUNTRY/REGION, 2015-2022 (USD BILLION)
  • TABLE 66: BIOSENSORS MARKET IN EUROPE, BY APPLICATION, 2015-2022 (USD BILLION)
  • TABLE 67: BIOSENSORS MARKET IN APAC, BY COUNTRY/REGION, 2015-2022 (USD BILLION)
  • TABLE 68: BIOSENSORS MARKET IN APAC, BY APPLICATION, 2015-2022 (USD BILLION)
  • TABLE 69: BIOSENSORS MARKET IN ROW, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 70: NEW PRODUCT LAUNCHES AND DEVELOPMENTS (2014-2017)
  • TABLE 71: PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS (2016-2017)
  • TABLE 72: MERGERS AND ACQUISITIONS (2015-2017)
  • TABLE 73: EXPANSIONS (2016 & 2017)

LIST OF FIGURES

  • FIGURE 1: BIOSENSOR MARKET: PROCESS FLOW OF MARKET SIZE ESTIMATION
  • FIGURE 2: BIOSENSORS MARKET: RESEARCH DESIGN
  • FIGURE 3: BIOSENSORS MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 4: BIOSENSORS MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 5: DATA TRIANGULATION
  • FIGURE 6: POINT OF CARE APPLICATIONS TO HOLD THE LARGEST SIZE OF THE BIOSENSORS MARKET BY 2022
  • FIGURE 7: NON-WEARABLE TO DOMINATE THE BIOSENSORS MARKET DURING FORECAST PERIOD
  • FIGURE 8: MARKET FOR OPTICAL BIOSENSORS TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
  • FIGURE 9: NORTH AMERICA TO HOLD THE LARGEST SHARE OF THE BIOSENSORS MARKET IN 2017
  • FIGURE 10: BIOSENSORS MARKET IN APAC TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 11: POINT OF CARE TO HOLD THE LARGEST SIZE OF THE BIOSENSORS MARKET BY 2022
  • FIGURE 12: ELECTROCHEMICAL BIOSENSORS TO HOLD THE LARGEST SHARE OF THE BIOSENSORS MARKET IN 2017
  • FIGURE 13: NON-WEARABLE BIOSENSORS TO HOLD A LARGER SHARE OF THE BIOSENSORS MARKET BY 2022
  • FIGURE 14: US TO HOLD THE LARGEST SHARE OF THE BIOSENSORS MARKET IN 2017
  • FIGURE 15: INCREASED MONITORING OF DIABETIC INDIVIDUALS AND DEMAND FOR HOME-BASED PC DEVICES TO FUEL THE GROWTH OF THE BIOSENSORS MARKET
  • FIGURE 17: MINIATURIZATION - A LEADING TREND IN THE CURRENT BIOSENSORS MARKET
  • FIGURE 18: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 19: LOW IMPACT OF THE THREAT OF NEW ENTRANTS ON THE BIOSENSORS MARKET
  • FIGURE 20: MEDIUM IMPACT OF THE THREAT OF SUBSTITUTE ON THE BIOSENSORS MARKET
  • FIGURE 21: MEDIUM IMPACT OF THE BARGAINING POWER OF SUPPLIER ON THE BIOSENSORS MARKET
  • FIGURE 22: HIGH IMPACT OF THE BARGAINING POWER OF BUYERS ON THE BIOSENSORS MARKET
  • FIGURE 23: MEDIUM IMPACT OF THE INTENSITY OF COMPETITIVE RIVALRY ON THE BIOSENSORS MARKET
  • FIGURE 24: TOTAL INVESTMENT RAISED BY THE START-UPS
  • FIGURE 25: BIOSENSORS MARKET, BY TECHNOLOGY
  • FIGURE 26: SEGMENTATION OF ELECTROCHEMICAL BIOSENSORS
  • FIGURE 27: SEGMENTATION OF OPTICAL BIOSENSORS
  • FIGURE 28: SEGMENTATION OF PIEZOELECTRIC BIOSENSORS
  • FIGURE 29: BIOSENSORS MARKET, BY PRODUCT
  • FIGURE 30: BIOSENSORS MARKET, BY APPLICATION (2017-2022)
  • FIGURE 31: BIOSENSORS MARKET FOR POC APPLICATIONS IN APAC TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
  • FIGURE 32: NORTH AMERICA TO HOLD THE LARGEST SIZE OF THE BIOSENSORS MARKET FOR GLUCOSE MONITORING APPLICATIONS BY 2022
  • FIGURE 33: EUROPE TO HOLD THE LARGEST SHARE OF THE BIOSENSORS MARKET FOR COAGULATION MONITORING APPLICATIONS BY 2022
  • FIGURE 34: EUROPE TO HOLD THE LARGEST SIZE OF THE BIOSENSORS MARKET FOR TUMOR OR CANCER MARKERS IN 2017
  • FIGURE 35: NORTH AMERICA TO HOLD THE LARGEST SHARE OF THE BIOSENSORS MARKET FOR HOME DIAGNOSTICS APPLICATIONS BY 2022
  • FIGURE 36: NON-WEARABLE BIOSENSORS TO HOLD A LARGER SHARE OF THE BIOSENSORS MARKET FOR HOME DIAGNOSTICS APPLICATIONS BY 2022
  • FIGURE 37: BIOSENSORS MARKET FOR RESEARCH LAB APPLICATIONS IN APAC TO GROW AT THE HIGHEST RATE BETWEEN 2017 AND 2022
  • FIGURE 38: NON-WEARABLE BIOSENSORS TO DOMINATE THE BIOSENSORS MARKET FOR RESEARCH LAB APPLICATIONS DURING THE FORECAST PERIOD
  • FIGURE 39: BIOSENSORS MARKET FOR BIODEFENSE APPLICATIONS IN APAC TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
  • FIGURE 40: MARKET FOR WEARABLE BIOSENSORS FOR BIODEFENSE APPLICATIONS TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
  • FIGURE 41: BIOSENSORS MARKET FOR ENVIRONMENTAL MONITORING APPLICATIONS IN APAC TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
  • FIGURE 42: MARKET FOR WEARABLE SENSORS FOR ENVIRONMENTAL MONITORING APPLICATIONS TO GROW AT A HIGHER RATE DURING THE FORECAST PERIOD
  • FIGURE 43: GEOGRAPHIC SNAPSHOT OF THE BIOSENSORS MARKET (2016)
  • FIGURE 44: SNAPSHOT OF THE BIOSENSORS MARKET IN NORTH AMERICA
  • FIGURE 45: SNAPSHOT OF THE BIOSENSORS MARKET IN EUROPE
  • FIGURE 46: SNAPSHOT OF THE BIOSENSORS MARKET IN APAC
  • FIGURE 47: MARKET SHARE ANALYSIS OF KEY PLAYERS IN THE BIOSENSORS INDUSTRY, 2016
  • FIGURE 48: BIOSENSORS MARKET OVERVIEW: DIVE ANALYSIS
  • FIGURE 49: MARKET EVOLUTION FRAMEWORK-NEW PRODUCT LAUNCHES/DEVELOPMENTS EMERGED AS THE MAJOR STRATEGY ADOPTED BY THE MARKET PLAYERS
  • FIGURE 50: BATTLE FOR MARKET SHARE: NEW PRODUCT LAUNCHES AND DEVELOPMENTS WERE THE KEY GROWTH STRATEGIES
  • FIGURE 51: ABBOTT LABORATORIES: COMPANY SNAPSHOT
  • FIGURE 52: ABBOTT LABORATORIES: PRODUCTS OFFERINGS
  • FIGURE 53: ABBOTT LABORATORIES: BUSINESS STRATEGIES
  • FIGURE 54: F. HOFFMAN-LA ROCHE LTD.: BUSINESS OVERVIEW
  • FIGURE 55: F. HOFFMAN-LA ROCHE LTD.: PRODUCTS OFFERINGS
  • FIGURE 56: F. HOFFMAN-LA ROCHE LTD.: BUSINESS STRATEGIES
  • FIGURE 57: MEDTRONIC, INC.: BUSINESS OVERVIEW
  • FIGURE 58: MEDTRONIC, INC.: PRODUCTS OFFERINGS
  • FIGURE 59: MEDTRONIC, INC.: BUSINESS STRATEGIES
  • FIGURE 60: UNIVERSAL BIOSENSORS, INC.: BUSINESS OVERVIEW
  • FIGURE 61: UNIVERSAL BIOSENSORS, INC.: PRODUCTS OFFERINGS
  • FIGURE 62: UNIVERSAL BIOSENSORS, INC.: BUSINESS STRATEGIES
  • FIGURE 63: SIEMENS AG: BUSINESS OVERVIEW
  • FIGURE 64: SIEMENS AG: PRODUCTS OFFERINGS
  • FIGURE 65: SIEMENS AG: BUSINESS STRATEGIES
  • FIGURE 66: LIFESCAN, INC.: PRODUCTS OFFERINGS
  • FIGURE 67: LIFESCAN, INC.: BUSINESS STRATEGIES
  • FIGURE 68: LIFESENSORS, INC.: PRODUCTS OFFERINGS
  • FIGURE 69: LIFESENSORS, INC.: BUSINESS STRATEGIES
  • FIGURE 70: NOVA BIOMEDICAL: PRODUCTS OFFERINGS
  • FIGURE 71: NOVA BIOMEDICAL: BUSINESS STRATEGIES
  • FIGURE 72: ACON LABORATORIES, INC.: PRODUCTS OFFERINGS
  • FIGURE 73: ACON LABORATORIES, INC.: BUSINESS STRATEGIES
  • FIGURE 74: PHARMACO-KINESIS CORPORATION: PRODUCTS OFFERINGS
  • FIGURE 75: PHARMACO-KINESIS CORPORATION: BUSINESS STRATEGIES
  • FIGURE 76: BAYER HEALTHCARE AG: BUSINESS OVERVIEW
  • FIGURE 77: BAYER HEALTHCARE AG: PRODUCTS OFFERINGS
  • FIGURE 78: BAYER HEALTHCARE AG: BUSINESS STRATEGIES
  • FIGURE 79: BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
  • FIGURE 80: BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERINGS
  • FIGURE 81: BIO-RAD LABORATORIES, INC.: BUSINESS STRATEGIES
  • FIGURE 82: DUPONT: COMPANY SNAPSHOT
  • FIGURE 83: DUPONT: PRODUCTS OFFERINGS
  • FIGURE 84: DUPONT: BUSINESS STRATEGIES
  • FIGURE 85: SYSMEX CORPORATION: COMPANY SNAPSHOT
  • FIGURE 86: SYSMEX CORPORATION: PRODUCTS OFFERINGS
  • FIGURE 87: SYSMEX CORPORATION: BUSINESS STRATEGIES
Back to Top